After-Hours Stock Movers:
Wendy's (NASDAQ:WEN) 16% HIGHER; long-time shareholder Nelson Peltz of Trian Fund Management said they are exploring a potential transaction, including a possible merger.
Nordstrom (NYSE:JWN) 12% HIGHER; reported Q1 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $3.57 billion versus the consensus estimate of $3.27 billion. Nordstrom sees FY2022 EPS of $3.20-$3.50, versus the consensus of $3.12.
Caleres (NYSE:CAL) 12% HIGHER; reported Q1 EPS of $1.32, $0.49 better than the analyst estimate of $0.83. Revenue for the quarter came in at $735.1 million versus the consensus estimate of $677.28 million. The company now expects consolidated sales levels to be up between 2 percent and 5 percent when compared to fiscal year 2021 and expects earnings per diluted share to be between $4.20 and $4.40, representing another year of record or near-record earnings for the organization.
Chinook Therapeutics Inc (NASDAQ:KDNY) 7% LOWER; commenced an underwritten public offering of its common stock,
Toll Brothers (NYSE:TOL) 4% HIGHER; reported Q2 EPS of $1.85, $0.31 better than the analyst estimate of $1.54. Revenue for the quarter came in at $2.28 billion versus the consensus estimate of $2.06 billion. Backlog value was $11.7 billion at second quarter end, up 35% compared to FY 2021’s second quarter; homes in backlog were 11,768, up 16%.
Intuit (NASDAQ:INTU) 3% HIGHER; reported Q3 EPS of $7.65, $0.07 better than the analyst estimate of $7.58. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.51 billion. Intuit sees FY2022 EPS of $11.68-$11.74, versus the consensus of $11.66. Intuit sees FY2022 revenue of $12.633-12.674 billion, versus the consensus of $12.32 billion.
Trevi Therapeutics (NASDAQ:TRVI) 3% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $10.
Macy's, Inc. (NYSE:M) 2% HIGHER; gains on strong results from peer Nordstrom's
Agilent Technologies (NYSE:A) 2% HIGHER; reported Q2 EPS of $1.13, $0.09 better than the analyst estimate of $1.04. Revenue for the quarter came in at $1.61 billion versus the consensus estimate of $1.5 billion. Agilent Technologies sees Q3 2022 EPS of $1.20-$1.22, versus the consensus of $1.12. Agilent Technologies sees Q3 2022 revenue of $1.625-1.65 billion, versus the consensus of $1.56 billion.